Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-25 @ 3:57 AM
NCT ID:
NCT00182702
Brief Title:
Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer
Official Title:
A Phase II Trial of BMS 247550 (Ixabepilone) in Advanced Renal Cell Carcinoma
Study:
NCT00182702
Protocol Section:
NCT00182702